Linked Life Data

2367392

Source:http://linkedlifedata.com/resource/pubmed/id/2367392

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1990-8-14
pubmed:abstractText
Euphylong is a theophylline preparation with new galenic slow-release design (micropellets in a capsule), developed for daily single-dose administration in the evening. It has been shown that the majority of patients with bronchial asthma, chronic obstructive bronchitis or emphysema who receive a single evening dose of Euphylong have a theophylline serum concentration that remains within the therapeutic range for 24 hours when the theophylline serum concentration measured at 8 a.m. under steady-state conditions is found to lie within the therapeutic range.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0934-8387
pubmed:author
pubmed:issnType
Print
pubmed:volume
44 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
287-8
pubmed:dateRevised
2009-4-7
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
[Dose titration with Euphylong following prior determination of serum concentration in the steady state].
pubmed:affiliation
Abt. Pneumologie, Medizinische Universitätsklinik, Homburg/Saar.
pubmed:publicationType
Journal Article, English Abstract